Latest News

Vermillion Pays Health Discovery Corporation Final Patent Infringement Settlement Payment

Data on ATL1101 Prostate Tumour Suppression Published in Scientific Journal & Australian Patent Granted

Repligen Receives Notice of Allowance for Recombinant Protein A Patent

Rosetta Genomics Announces Issuance of Three U.S. Patents

Chemel delivers a biosensor to its first customer in Austria

NanoBio Awarded Key Patent Covering Vaccine and Anti-infective Platforms

Cytheris Announces Notice of Allowance for U.S. Patent Covering the Preparation and Uses of its Glycosylated Recombinant Human Interleukin-7 (CYT107)

ArmaGen receives Notice of Allowance from USPTO on broad therapeutic antibody delivery patent.

NanoInk's Nano BioDiscovery Division Launches Premiere Nanoscale Protein Array Assay

Cordis Corporation Announces Agreement With Boston Scientific To Resolve Certain Coronary Stent Patent Disputes

More news... | RSS Feed...

Most Viewed

Teva Announces Settlement Agreements With AstraZeneca Regarding Generic Prilosec

Wockhardt receives US FDA approval for Alzheimer's drug Memantine

Watson Files FDA Application for Generic Nuvigil(R)

Skinvisible Licensee Announces Agreement with Walgreens

Allon receives Japanese patent allowance for treatment and prevention of major neurological diseases

Wockhardt receives US FDA approval for antibacterial Levofloxacin

Hi-Tech Pharmacal's ECR Subsidiary to Launch a New Dermatitis Treatment

Cipher secures summary judgment in the company's favour in pending patent litigation involving CIP-TRAMADOL ER

Living Cell Technologies Granted European Patent for Neurological Disease Product NTCELL

Mylan Confirms First-to-File Patent Challenge Relating to Sleep-Disorder Drug Nuvigil

Therapeutic Target

Cardiovascular

Dermatology

Endocrine and Metabolic

Gastroenterology

Genitourinary

Hematology

Immunology and Allergy

Infection

Musculoskeletal

Neurology

Obstetrics and Gynecology

Oncology

Ophthalmology

Psychiatry

Pulmonary

Categories

Deals and Alliances

Development

Financial Results

Financings

Intellectual Property

Regulatory

Press releases

Deals review

Headlines

PR Newswire